Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus
- PMID: 20532480
- DOI: 10.1007/s00198-010-1310-6
Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus
Abstract
Although previous studies indicated that serum insulin-like growth factor-I (IGF-I) was inversely associated with the presence of vertebral fractures (VFs), little is known whether serum IGF-I is associated with multiple VFs. We report that serum IGF-I could be clinically useful for assessing the severity of VFs in type 2 diabetic postmenopausal women.
Introduction: The number of VFs is associated with the mobility and mortality of the elderly people. Although serum IGF-I is inversely associated with the presence of VFs, little is known about the relationship between serum IGF-I and multiple VFs.
Methods: In this cross-sectional study, we recruited 479 men and 334 postmenopausal women with type 2 diabetes mellitus and measured serum IGF-I, bone mineral density, and bone turnover markers. Lateral X-ray films of the thoracic and lumbar spine were taken to diagnose the VF.
Results: In postmenopausal women, serum IGF-I level was decreased when the number of VFs was increased [no VFs; 138 ± 51 ng/ml (mean ± SD) vs. one VF; 119 ± 42 (p = 0.006), two VFs; 103 ± 39 (p = 0.002), and three and more VFs; 91 ± 40 (p < 0.001)]. Multiple logistic regression analysis adjusted for age, duration of diabetes, body mass index, serum creatinine, and HbA(1c) showed that serum IGF-I level was inversely associated with the presence of one VF [odds ratio (OR) = 0.67, p = 0.029], two VFs (OR = 0.40, p = 0.017), as well as three and more VFs (OR = 0.27, p = 0.005). These associations were still significant after the additional adjustment for BMD at the lumbar spine. In contrast, no significant association of serum IGF-I level with VFs was found in men.
Conclusions: Serum IGF-I level was inversely associated with the number of prevalent VFs in postmenopausal women with type 2 diabetes, suggesting that serum IGF-I could be clinically useful for assessing the severity of VFs in the population.
Similar articles
-
Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.Osteoporos Int. 2018 Nov;29(11):2527-2535. doi: 10.1007/s00198-018-4638-y. Epub 2018 Jul 20. Osteoporos Int. 2018. PMID: 30030585
-
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.Bone. 2013 Oct;56(2):355-62. doi: 10.1016/j.bone.2013.06.029. Epub 2013 Jul 9. Bone. 2013. PMID: 23845326
-
Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.Osteoporos Int. 2007 Dec;18(12):1675-81. doi: 10.1007/s00198-007-0430-0. Epub 2007 Jul 14. Osteoporos Int. 2007. PMID: 17632742
-
Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women.Intern Med. 2017;56(3):269-273. doi: 10.2169/internalmedicine.56.7416. Epub 2017 Feb 1. Intern Med. 2017. PMID: 28154269 Free PMC article.
-
Opportunistic diagnosis of osteoporotic vertebral fractures on standard imaging performed for alternative indications.BJR Open. 2021 Dec 17;3(1):20210053. doi: 10.1259/bjro.20210053. eCollection 2021. BJR Open. 2021. PMID: 35707752 Free PMC article. Review.
Cited by
-
Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.J Clin Endocrinol Metab. 2023 May 8;108(10):e923-36. doi: 10.1210/clinem/dgad255. Online ahead of print. J Clin Endocrinol Metab. 2023. PMID: 37155585 Free PMC article.
-
Type 2 diabetes and bone fragility in children and adults.World J Diabetes. 2022 Nov 15;13(11):900-911. doi: 10.4239/wjd.v13.i11.900. World J Diabetes. 2022. PMID: 36437868 Free PMC article. Review.
-
The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment.Pharmaceuticals (Basel). 2022 Oct 17;15(10):1274. doi: 10.3390/ph15101274. Pharmaceuticals (Basel). 2022. PMID: 36297386 Free PMC article. Review.
-
Fracture risk assessment in diabetes mellitus.Front Endocrinol (Lausanne). 2022 Sep 2;13:961761. doi: 10.3389/fendo.2022.961761. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120431 Free PMC article. Review.
-
Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes.Osteoporos Int. 2021 Jun;32(6):1165-1173. doi: 10.1007/s00198-020-05790-6. Epub 2021 Jan 7. Osteoporos Int. 2021. PMID: 33415372
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous